UPDATE: Citi Upgrades Mylan (MYL) to Buy
Tweet
Share
E-mail
Get Alerts MYL Hot Sheet
Price: $15.86 --0%
Rating Summary:
17 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
17 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
(Updated - August 16, 2017 6:24 AM EDT)
(updated to add analyst comment)
Citi upgraded Mylan (NASDAQ: MYL) from Neutral to Buy with a price target of $42.00 (from $36.00).
Analyst Liav Abraham sees optionality on differentiated and durable generics portfolio and likes the broad pipeline of complex generics/biosimilars. The analyst views MYL as best positioned to execute in a challenging environment.
For an analyst ratings summary and ratings history on Mylan click here. For more ratings news on Mylan click here.
Shares of Mylan closed at $30.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Compass Point Upgrades Strawberry Fields REIT (STRW) to Buy
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho
- Citi upgrades Bath & Body Works to Buy with $25 price target
Create E-mail Alert Related Categories
Analyst Comments, Hot Upgrades, UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
